Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Publish with us
About the journal
Meet the editors
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Publish with us
About the journal
Meet the editors
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 1, Issue 1
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Research
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
Online download statistics by month:
Online download statistics by month: June 2022 to April 2023
Abstract
Full
Pdf
Jun 2022
866
849
153
Jul 2022
915
870
213
Aug 2022
143
100
37
Sep 2022
123
92
24
Oct 2022
150
99
31
Nov 2022
158
136
53
Dec 2022
200
195
35
Jan 2023
121
117
15
Feb 2023
122
116
77
Mar 2023
154
147
73
Apr 2023
117
107
64
Total
3069
2828
775
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF